Status:
COMPLETED
Metabolic Syndrome and Contrast Induced Nephropathy
Lead Sponsor:
Ankara University
Conditions:
Contrast Induced Nephropathy
Metabolic Syndrome
Eligibility:
All Genders
18-80 years
Brief Summary
Prevention of contrast induced nephropathy after interventional cardiologic procedures deserves close interest because of its association with prolonged hospitalization, increased cost and increased i...
Eligibility Criteria
Inclusion
- Patients must be scheduled for elective percutaneous coronary intervention Clinical diagnosis of metabolic syndrome Patients must give informed consent
Exclusion
- Acute coronary events Acute renal failure End stage renal failure requiring hemodialysis Contrast allergy and exposure to nephrotoxic agent within 1 week before percutaneous coronary intervention Exposure to contrast agent within 1 week before the procedure.
Key Trial Info
Start Date :
February 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
599 Patients enrolled
Trial Details
Trial ID
NCT02192372
Start Date
February 1 2014
End Date
July 1 2014
Last Update
July 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara University School Of Medicine, Department of Cardiology
Ankara, Turkey (Türkiye), 06230